Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Protein Phosphorylation Ser / Thr Kinases MAPK Pathway

Recombinant human ZAK protein (ab89852)

Price and availability

278 083 ₸

Availability

Order now and get it on Tuesday March 09, 2021

Recombinant human ZAK protein (ab89852)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Expression system: Baculovirus infected Sf9 cells
  • Active: Yes
  • Suitable for: SDS-PAGE, WB, Functional Studies

You may also be interested in

Product image
Anti-TRIB1 antibody (ab134809)
Product image
Human LAMTOR3 (MAP2K1IP1) knockout HeLa cell line (ab265624)
Product image
Anti-WDR26 antibody (ab85961)
Product image
Alexa Fluor® 488 Anti-TAK1 antibody [EPR5984] (ab199191)

Description

  • Product name

    Recombinant human ZAK protein
  • Biological activity

    The specific activity of ab89852 was determined to be 62 nmol/min/mg
  • Expression system

    Baculovirus infected Sf9 cells
  • Accession

    D4Q8H0
  • Protein length

    Full length protein
  • Animal free

    No
  • Nature

    Recombinant
    • Species

      Human

Preparation and Storage

  • Applications

    SDS-PAGE

    Western blot

    Functional Studies

  • Form

    Liquid
  • Additional notes

    ab64311 (Myelin Basic Protein protein) can be utilized as a substrate for assessing kinase activity

  • Concentration information loading...

Images

  • Functional Studies - Recombinant human ZAK protein (ab89852)
    Functional Studies - Recombinant human ZAK protein (ab89852)
    The specific activity of ZAK (ab89852) was determined to be 19.8 nmol/min/mg as per activity assay protocol and was equivalent to 60 nmol/min/mg as per radiometric assay
  • SDS-PAGE - Recombinant human ZAK protein (ab89852)
    SDS-PAGE - Recombinant human ZAK protein (ab89852)
    SDS PAGE analysis of ab89852
  • SDS-PAGE - Recombinant human ZAK protein (ab89852)
    SDS-PAGE - Recombinant human ZAK protein (ab89852)
    SDS PAGE analysis of ab89852
  • SDS-PAGE - Recombinant human ZAK protein (ab89852)
    SDS-PAGE - Recombinant human ZAK protein (ab89852)
    SDS-PAGE showing ab89852 at approximately 82kDa
  • Functional Studies - Recombinant human ZAK protein (ab89852)
    Functional Studies - Recombinant human ZAK protein (ab89852)
    Kinase Assay demonstrating specific activity of ab89852

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Caldesmon/CDM antibody (ab68878)

  •  
  • Product image

    Anti-Nrf2 antibody (ab92946)

  •  
  • Product image

    Anti-WEE2 antibody (ab121943)

  •  
  • Product image

    Anti-CRLF1 antibody (ab96366)

  •  
  • Product image

    Recombinant mouse IL-6 protein (ab198572)

  •  
  • Product image

    Anti-Dynamin 1 antibody (ab3456)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.